Anemia in Chronic Obstructive Pulmonary Disease and the Potential Role of Iron Deficiency

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 1, 2016, Pages 100-109

  Vasquez, Amber ^a   Logomarsino, John V ^a  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

health care cost; inflammation; mortality; quality of life

Indexed keywords

IRON;

ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INFLAMMATION; IRON DEFICIENCY; IRON INTAKE; LUNG FUNCTION; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SCREENING; SUPPLEMENTATION; TREATMENT OUTCOME; ANEMIA, IRON-DEFICIENCY; COMPLICATION; DIETARY SUPPLEMENT; PATHOPHYSIOLOGY;

ANEMIA; ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; HUMANS; IRON; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84955363400     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1043519     Document Type: Article

References (63)

1. Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61 (46): 938-943.
2. Schneckenpointner R, Jörres RA, Meidenbauer N, et al. The clinical significance of anaemia and disturbed iron homeostasis in chronic respiratory failure. Int J Clin Pract 2014; 68 (1): 130-138.
3. Halpern MT, Zilberberg MD, Schmier JK, et al. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006; 4: 17.
4. Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006; 6: 23.
5. Kollert F, Tippelt A, Müller C, et al. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care 2013; 58 (7): 1204-1212.
6. Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29 (5): 923-929.
7. Chambellan A, Chailleux E, Similowski T., ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128 (3): 1201-1208.
8. Boutou AK, Stanopoulos I, Pitsiou GG, et al. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration 2011; 82 (3): 237-245.
9. Boutou AK, Karrar S, Hopkinson NS, Polkey MI. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration 2013; 85 (2): 126-131.
10. Martinez-Rivera C, Portillo K, Munõz-Ferrer A, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012; 9 (3): 243-250.
11. Shorr AF, Doyle J, Stern L, et al. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin 2008; 24 (4): 1123-1130.
12. Ozyilmaz E, Kokturk N, Teksut G, Tatlicioglu T. Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Int J Clin Pract 2013; 67 (7): 691-697.
13. Yohannes AM, Ershler WB. Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care 2011; 56 (5): 644-652.
14. Silverberg DS, Mor R, Weu MT, et al. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med 2014; 14: 24.
15. Kollert F, Müller C, Tippelt A, et al. Anaemia in chronic respiratory failure. Int J Clin Pract 2011; 65 (4): 479-486.
16. John M, Lange A, Hoernig S, et al. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006; 111 (3): 365-70.
17. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007; 370 (9589): 797-799.
18. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379 (9823): 1341-1351.
19. Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010; 31 (15): 1872-1880.
20. Jankowska EA, von Haehling S, Anker SD, et al. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013; 34 (11): 816-829.
21. Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 2012; 14 (4): 423-429.
22. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113 (9): 1271-1276.
23. John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest 2005; 127 (3): 825-829.
24. Boutou AK, Pitsiou GG, Stanopoulos I, et al. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM 2012; 105 (7): 657-663.
25. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48 (7): 1066-1076.
26. Duru S, Bilgin E, Ardiç S. Hepcidin: A useful marker in chronic obstructive pulmonary disease. Ann Thorac Med 2012; 7 (1): 31-35.
27. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33 (5): 1165-1185.
28. Shrikrishna D, Hopkinson NS. Chronic obstructive pulmonary disease: consequences beyond the lung. Clin Med 2012; 12 (1): 71-74.
29. Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol 2011; 154 (3): 289-300.
30. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am 2014; 28 (4): 671-681, vi.
31. Gangat N, Wolanskyj AP. Anemia of chronic disease. Semin Hematol 2013; 50 (3): 232-238.
32. Poggiali E, Migone De Amicis M, Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med 2014; 25 (1): 12-17.
33. Marković M, Majkić-Singh N, Ignjatović S, Singh S. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation. Int J Lab Hematol 2007; 29 (5): 341-346.
34. Thomas DW, Hinchliffe RF, Briggs C, et al. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol 2013; 161 (5): 639-648.
35. McKeever TM, Lewis SA, Smit HA, et al. A multivariate analysis of serum nutrient levels and lung function. Respir Res 2008; 9: 67.
36. Obase Y, Mouri K, Shimizu H, et al. Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD. Int J Chron Obstruct Pulmon Dis 2011; 6: 679-683.
37. Hirayama F, Lee AH, Oura A, et al. Dietary intake of six minerals in relation to the risk of chronic obstructive pulmonary disease. Asia Pac J Clin Nutr 2010; 19 (4): 572-577.
38. Smith TG, Balanos GM, Croft QP, et al. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol 2008; 586 (Pt 24): 5999-6005.
39. Markoulaki D, Kostikas K, Papatheodorou G, et al. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med 2011; 22 (1): 103-107.
40. Tassiopoulos S, Kontos A, Konstantopoulos K, et al. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 2001; 95 (6): 471-475.
41. Pavlisa G, Vrbanic V, Kusec V, Jaksic B. Erythropoietin response after correction of severe hypoxaemia due to acute respiratory failure in chronic obstructive pulmonary disease patients. Clin Sci (Lond) 2004; 106 (1): 43-51.
42. Sala E, Balaguer C, Villena C, et al. Low erythropoietin plasma levels during exacerbations of COPD. Respiration 2010; 80 (3): 190-197.
43. Schönhofer B, Böhrer H, Köhler D. Blood transfusion facilitating difficult weaning from the ventilator. Anaesthesia 1998; 53 (2): 181-184.
44. Schönhofer B, Wenzel M, Geibel M, Köhler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998; 26 (11): 1824-1828.
45. Creutzberg EC, Wouters EF, Mostert R, et al. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 2003; 124 (5): 1733-1742.
46. Vaziri ND. Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis. Am J Kidney Dis 2013; 61 (6): 992-1000.
47. Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2009; 2: 2.
48. Steinbicker AU, Muckenthaler MU. Out of balance-systemic iron homeostasis in iron-related disorders. Nutrients. 2013; 5 (8): 3034-3061.
49. Puntarulo S. Iron, oxidative stress and human health. Mol Aspects Med 2005; 26 (4-5): 299-312.
50. Van Buren P, Velez RL, Vaziri ND, Zhou XJ. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol 2012; 44 (2): 499-507.
51. Qunibi WY. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: A review. Arzneimittelforschung 2010; 60 (6a): 399-412.
52. Philippot Q, Desleé G, Adair-Kirk TL, et al. Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. PLoS One 2014; 9 (5): e96285.
53. Ross EM. Evaluation and treatment of iron deficiency in adults. Nutr Clin Care 2002; 5 (5): 220-224.
54. Kurtoglu E, Ugur A, Baltaci AK, Undar L. Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia. Biol Trace Elem Res 2003; 96 (1-3): 117-123.
55. Isler M, Delibas N, Guclu M, et al. Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effects of different treatment modalities. Croat Med J 2002; 43 (1): 16-19.
56. Kumbasar A, Gursu M, Kaya C, et al. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients. J Nephrol 2012; 25 (5): 825-832.
57. Cavdar C, Temiz A, Yeniçerioʇlu Y, et al. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Scand J Urol Nephrol 2003; 37 (1): 77-82.
58. Schrier SL, Auerbach M. Treatment of the adult with iron deficiency anemia. In: UpToDate, Post TW. (Ed), UpToDate, Waltham, MA. (accessed September 25, 2014).
59. INFED (iron dextran injection USP). Morristown (NJ): Watson Pharma, Inc.; 2009 Sept. Package insert. Available from: http://pi.actavis.com/data
60. Ferrlecit (sodium ferric gluconate complex in sucrose injection). Bridgewater (NJ): Sanofi-Aventis U.S. LLC; 2011 Aug. Package insert. http://www.products.sanofi-aventis.us/ferrlecit/ferrlecit.pdf. (accessed 9 October, 2014).
61. Feraheme (ferumoxytol) Injection. Waltham (MA): AMAG Pharmaceuticals, Inc.; 2013 Dec. Package insert. http://www.feraheme.com/pdfs/Feraheme-Prescribing-Information.pdf. (accessed 9 October, 2014).
62. Venofer (iron sucrose injection, USP). Shirley (NY): American Regent, Inc.; 2014 Jan. Package insert. Available from: http://www.venofer.com/PDF/Venofer-Insert-Rev-012014.pdf. (accessed 9 October, 2014).
63. Injectafer (ferric carboxymaltose injection). Shirley (NY): American Regent, Inc.; 2013 July. Package insert. Available from: http://www.injectafer.com/files/Prescribing-Information.pdf. (accessed 9 October, 2014).